Guest guest Posted June 19, 2011 Report Share Posted June 19, 2011 Causes of Death Among People with Hepatitis B and CSUMMARY Deaths due to most liver-related causes dropped among people with hepatitis B, and people with hepatitis C were less likely to die of drug-related causes, but mortality due to hepatocellular carcinoma remained stable, according to a large Australian study. Coinfection with HIV increased mortality significantly.Vertex Licenses Alios HCV Protease InhibitorsSUMMARY Vertex Pharmaceuticals and Alios BioPharma have agreed to collaborate on development of 2 novel nucleotide analog HCV NS5B polymerase inhibitor candidates, now at the preclinical stage.Sitges Meeting Discusses European Access to New Hepatitis C DrugsSUMMARY Community activists, researchers, and regulatory and pharmaceutical representatives met this month in Sitges, Spain, to discuss early and expanded access to direct-acting antiviral agents for hepatitis C, especially for difficult-to-treat patients including those with HIV/HCV coinfection and cirrhosis. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 19, 2011 Report Share Posted June 19, 2011 Causes of Death Among People with Hepatitis B and CSUMMARY Deaths due to most liver-related causes dropped among people with hepatitis B, and people with hepatitis C were less likely to die of drug-related causes, but mortality due to hepatocellular carcinoma remained stable, according to a large Australian study. Coinfection with HIV increased mortality significantly.Vertex Licenses Alios HCV Protease InhibitorsSUMMARY Vertex Pharmaceuticals and Alios BioPharma have agreed to collaborate on development of 2 novel nucleotide analog HCV NS5B polymerase inhibitor candidates, now at the preclinical stage.Sitges Meeting Discusses European Access to New Hepatitis C DrugsSUMMARY Community activists, researchers, and regulatory and pharmaceutical representatives met this month in Sitges, Spain, to discuss early and expanded access to direct-acting antiviral agents for hepatitis C, especially for difficult-to-treat patients including those with HIV/HCV coinfection and cirrhosis. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.